Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Ratos Capital/Financing Update 2007

Nov 28, 2007

2957_rns_2007-11-28_68f2aa5e-72a2-42a5-aa24-aa75e6218559.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

Ratos AB (publ), Drottninggatan 2 Box 1661 SE-111 96 Stockholm Sweden Org nr/Corp. Id. no. 556008-3585, Tel +46 8 700 17 00 Fax +46 8 10 25 59 www.ratos.se

P R E S S R E L E A S E 28 November 2007

Ratos discloses the information provided herein pursuant to the Swedish Securities Exchange and Clearing Operations Act and/or the Swedish Financial Instruments Trading Act. The information was submitted for publication at 08.30 CET, on 28 November, 2007.

Ratos releases SEK 500m by refinancing DIAB

Ratos and 3i have completed a refinancing of DIAB totalling SEK 1,000m, of which Ratos will receive SEK 500m. The refinancing was made possible by the company's favourable performance in recent years.

DIAB, which is 50% owned by Ratos, is the world leader in manufacturing and development of core materials for composite structures such as blades for wind turbines, boat hulls and decks, and components for aircraft, trains, buses and space rockets. The material has a unique combination of characteristics such as low weight, high strength, insulation properties and chemical resistance.

DIAB has had strong sales and earnings growth over the past five years. In 2006, sales totalled SEK 1,205m and operating profit (EBITA) reached SEK 258m.

  • Ratos CEO Arne Karlsson: "DIAB has seen fantastic development which now makes a refinancing of the company possible. Our assessment is that the company's future prospects remain good, and the refinancing we are now carrying out will give the company a more efficient capital structure."

As a result of the refinancing the consolidated book value for DIAB in Ratos's consolidated balance sheet will be adjusted downwards by SEK 500m. The book value will thereby, combined with some other structural changes, amount to approximately SEK 325m, based on the book value at 30 September 2007. The refinancing of DIAB will have no earnings impact for Ratos.

The refinancing of DIAB is subject to approval from Bolagsverket in Sweden.

For further information, please contact Arne Karlsson, CEO Ratos, +46 8 700 17 00 Clara Bolinder-Lundberg, Head of Corporate Communications Ratos, +46 8 700 17 63

Financial calendar from Ratos: Year-end report 2007 21 February 2008 AGM 2008 9 April 2008 Interim report January – March 2008 8 May 2008 Interim report January – June 2008 22 August 2008 Interim report January – September 2008 7 November 2008

Ratos is a listed private equity company. The business concept is to maximise shareholder value over time by investing in, developing and divesting primarily unlisted companies. Ratos thus offers stock market players a unique investment opportunity. The equity of Ratos's investments is approximately SEK 11 billion and a market capitalisation of approximately SEK 30 billion. Ratos's holdings include AH Industries, Anticimex, Arcus Gruppen, Bisnode, Camfil, Contex, DIAB, EuroMaint, GS-Hydro, Haendig, Haglöfs, HL Display, HÅG/RH/RBM, Hägglunds Drives, Inwido, Jøtul, Lindab, MCC, Medifiq Healthcare, Superfos and Other holdings.